viewMarrone Bio Innovations

Marrone Bio dominates with its flagship Regalia brand emerging as top biofungicide in California

Regalia trounced competition by cornering over 25% market share of the foliar biofungicide segment in California between January-to-April

Marrone Bio Innovations - Marrone Bio dominates with its flagship Regalia product emerging as top biofungicide brand in California
The company's suite of biologicals includes a bevvy of bacteria strains and plant extracts that fight pests, control plant diseases and reduce stress from sun and water

Marrone Bio Innovations Inc (NASDAQ:MBII) (MBI) said Wednesday that its flagship biofungicide Regalia trounced competition by cornering over 25% market share of the foliar biofungicide segment in California between January-to-April, citing data from the California Department of Pesticide Regulation (CDPR).

The company’s Regalia biofungicide delivers better yield by stimulating a plant’s innate ability to fight diseases and is popular among farmers who grow specialty crops including hemp and cannabis.

“Regalia’s performance is a testament to its efficacy for managing plant diseases and improving crop health,” said Kevin Hammill, chief commercial officer for Marrone Bio.

READ: Marrone Bio says final candidate identified from nationwide CEO search efforts

“Its performance has been proven on domestic and international specialty crops for more than ten years. While the 2020 fungicide market in California is down overall, we are pleased to see that when growers used a biofungicide, they chose Regalia more often than direct competitors.”

Hammill added that the company’s newly approved biofungicide Stargus is also seeing a “very positive” response and “promising results” from field trials.

California’s conventional and organic fungicide market was down 14% between January-to-April due to less disease pressures resulting in fewer fungicide applications. Almonds, in particular, saw the greatest reduction in treated acres with a 21% decrease, said the company citing data from CDPR.

Despite the reduced fungicide use, Marrone Bio saw an uptick in the demand for Regalia and Stargus, on several crops including wine grapes and stone fruits.

Stargus which provides broad-spectrum disease control saw quick adoption after winning approval from the CDPR in January. Since then the product has undergone several label updates, including the addition of hemp and pome fruits, for all US states with updates pending in California for “key diseases on grapes and strawberries.”

Both Regalia and Stargus are exempt from maximum residue limits (MRLs) and are Organic Materials Review Institute (OMRI) listed.

Founded in 2006 in Davis, California, Marrone Bio holds more than 400 issued and pending patents and has brought six US Environmental Protection Agency-registered biological product lines and one biostimulant to market. 

Contact the author Uttara Choudhury at [email protected]

Follow her on Twitter: @UttaraProactive 

Quick facts: Marrone Bio Innovations

Price: 1.1 USD

Market: NASDAQ
Market Cap: $167.72 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Marrone Bio Innovations named herein, including the promotion by the Company of Marrone Bio Innovations in any Content on the Site, the Company...


Marrone Bio Innovations announces alliance with South American company...

Marrone Bio Innovations (NASDAQ: MBII) Chief Commerical Officer Kevin Hammill joined Steve Darling from Proactive to share news the company has taken a step forward on global expansion by announcing an alliance with the South American company Rizobacter to distribute novel plant health and crop...

on 09/25/2020

2 min read